Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

Sun Young Rha, Sun Young Rha, Do-Youn Oh et al. · The Lancet Oncology · 2023

Cited by 689 works. doi:10.1016/s1470-2045(23)00515-6

Authors

References